Blood

Vol. 147, Issue 20 Issue 20 2026
17
Articles

Articles in this Issue

Circular RNA in chronic myeloid leukemia

Carlo Gambacorti-Passerini May 14, 2026 pp. 2285-2286 10.1182/blood.2026033266

PU.1-activated genomic regions define low-risk MDS subsets characterized by immune dysregulation and disease progression

Veronica Vallelonga, Francesco Gandolfi, Matteo Zampini et al. May 14, 2026 pp. 2358-2374 10.1182/blood.2025030760

Abstract Myelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms associated with an increased risk of progression to secondary acute myeloid leukemia (sAML). This study...

Pruning the Waldenström macroglobulinemia evolutionary tree

Patrick Blaney, Gareth J. Morgan May 14, 2026 pp. 2279-2280 10.1182/blood.2026033492

Next-generation IHC: identifying <i>TP53</i> mutation origin in a bone marrow with concurrent CLL and AML

Mahreen Hussain, Sanam Loghavi May 14, 2026 pp. 2415-2415 10.1182/blood.2025032949

Proteasome subunit PSMD1 is a key therapeutic target in multiple myeloma

Ting Du, Teng Fang, Sindhu Pillai et al. May 14, 2026 pp. 2344-2357 10.1182/blood.2025029358

Abstract We found that PSMD1, a key subunit of the 19S proteasome regulatory particle, was overexpressed and correlated with poor prognosis in multiple myeloma (MM). Genetic deplet...

Nuclear transcriptional condensates as drivers and therapeutic targets in <i>NPM1</i> -mutated AML

Hannah J. Uckelmann, Jayant Y. Gadrey, Lorenzo Brunetti May 14, 2026 pp. 2291-2297 10.1182/blood.2025031880

Abstract NPM 1-mutated acute myeloid leukemia (AML) is driven by aberrant HOX/MEIS1 expression, whose mechanistic basis remained unresolved for years. Recent paradigm-shifting stud...

DHODH as a targetable metabolic Achilles’ heel for chemotherapy-resistant B-ALL

Yuxuan Liu, Haowen Jiang, Jingjing Liu et al. May 14, 2026 pp. 2328-2343 10.1182/blood.2025029264

Abstract Relapse remains a major barrier to survival in B-cell acute lymphoblastic leukemia (B-ALL). Both activation of B-cell signaling pathways and increased glucose consumption...

The role of activated platelets in cerebral malaria pathogenesis

Martin Schlesinger May 14, 2026 pp. 2286-2288 10.1182/blood.2026033345

CHIP and inflammatory bowel disease: adding fuel to the fire

David J. Curtis, Jasmine Singh May 14, 2026 pp. 2280-2281 10.1182/blood.2026033249

Anti-CD4 antibody–modulated transplants for GVHD prevention in hematopoietic cell transplantation

Kristina Roth, Dennis Loeffler, Conny Blumert et al. May 14, 2026 pp. 2402-2414 10.1182/blood.2025031370

Abstract Graft-versus-host disease (GVHD) remains one of the major complications following allogeneic hematopoietic cell transplantation. Currently, immunosuppressants are used for...

<i>circPCMTD1</i> : a protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> <i>1</i> -positive leukemias

Dimitrios Papaioannou, Amog P. Urs, Rémi Buisson et al. May 14, 2026 pp. 2375-2387 10.1182/blood.2025031129

Abstract Circular RNAs (circRNAs) are a novel class of RNA transcripts that regulate important cellular functions in health and disease. In this study, we report on the functional...

Inflammatory bowel disease–induced inflammation augments clonal hematopoiesis of indeterminate potential through Ref-1

Ramesh Kumar, Linke Li, Sarah Urbut et al. May 14, 2026 pp. 2315-2327 10.1182/blood.2025032339

Abstract Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by age-related somatic mutations in hematopoietic stem and progenitor cells (HSC/Ps) and is correla...

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia

Hao Sun, Romanos Sklavenitis-Pistofidis, Shirong Liu et al. May 14, 2026 pp. 2298-2314 10.1182/blood.2025032268

Abstract To elucidate the molecular basis underlying differential responses and resistance to ibrutinib in Waldenström macroglobulinemia (WM), we conducted a prospective phase 2 tr...

Heme-induced ITAM signaling exacerbates malaria-associated neuropathogenesis through activation of platelet mTOR

Irina Portier, Frederik Denorme, Neal D. Tolley et al. May 14, 2026 pp. 2388-2401 10.1182/blood.2025030841

Abstract Malaria, caused by Plasmodium parasites, has a worldwide disease burden of over 250 million cases and ∼600 000 deaths annually. A leading cause of malaria-associated morta...

PU.1 inflames lower-risk MDS

Julie A. I. Thoms, John E. Pimanda May 14, 2026 pp. 2283-2285 10.1182/blood.2026033252

One-time treatment to rule them all?

Annkristin Heine May 14, 2026 pp. 2288-2289 10.1182/blood.2026033165

PSMD1 and myeloma: striking the proteasome from a new angle

Enrico Milan, Simone Cenci May 14, 2026 pp. 2282-2283 10.1182/blood.2025033018

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page